This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Afzelia africana
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
West and Central African tree whose bark is used for sexually transmitted infections, malaria, and as an antimicrobial agent in traditional medicine.
West and Central African tree whose bark is used for sexually transmitted infections, malaria, and as an antimicrobial agent in traditional medicine. Key active compounds include afrormosin, quercetin, luteolin.
afrormosin, along with quercetin and luteolin, are the primary bioactive compounds in Afzelia Africana. These compounds modulates NF-κB and COX-2 inflammatory pathways, provides free radical scavenging activity, disrupts microbial cell membranes and inhibits pathogen growth.
Antimicrobial activity
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-inflammatory effects
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antioxidant properties
Wound healing
STI treatment
Based on traditional use; clinical evidence limited
Malaria
Based on traditional use; clinical evidence limited
Urinary infections
Based on traditional use; clinical evidence limited
Found an error or have a correction for Afzelia Africana?
Report an Issue →